APA

Borrello M. G., Alberti L., Arighi E., Bongarzone I., Battistini C., Bardelli A., Pasini B., Piutti C., Rizzetti M. G., Mondellini P., Radice M. T. & Pierotti M. A. (19960621). The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. : Molecular and cellular biology.

Chicago

Borrello M G, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti M G, Mondellini P, Radice M T and Pierotti M A. 19960621. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. : Molecular and cellular biology.

Harvard

Borrello M. G., Alberti L., Arighi E., Bongarzone I., Battistini C., Bardelli A., Pasini B., Piutti C., Rizzetti M. G., Mondellini P., Radice M. T. and Pierotti M. A. (19960621). The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. : Molecular and cellular biology.

MLA

Borrello M G, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti M G, Mondellini P, Radice M T and Pierotti M A. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. : Molecular and cellular biology. 19960621.